Non-muscle-invasive Bladder Cancer: Side-by-Side Guideline Comparison
OncologiaSobre o estudo
- Desenho
- Diretriz clínica
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- European urology focus
- Publicado em
- 10 jun 2023
- Citações
- 9
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Non-muscle-invasive Bladder Cancer: Side-by-Side Guideline Comparison
Janet Baack Kukreja
Descritores MeSH
- Urinary Bladder Neoplasms
- Non-Muscle Invasive Bladder Neoplasms
- Urology
- United States
- Neoplasm Invasiveness
- Humans
- Societies, Medical
Veja também
Estudos relacionados
- The current role of photodynamic diagnosis (PDD) in the management of non-muscle invasive bladder cancer: the Italian Society of Urology (SIU) Position Paper
- Guidelines of the Oncology Committee of the French Association of Urology (CCAFU) and the Infectious Diseases Committee of the French Association of Urology (CIAFU) for Intravesical Instillation of Mitomycin C, Epirubicin, and BCG in NMIBC
- ACR Appropriateness Criteria® Pretreatment Staging of Urothelial Cancer: 2024 Update
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update